RAD54B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.120060E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.697600E-01
Normal-vs-Stage2
3.605400E-04
Normal-vs-Stage3
4.940600E-01
Normal-vs-Stage4
2.698200E-01
Stage1-vs-Stage2
5.853600E-01
Stage1-vs-Stage3
8.686600E-01
Stage1-vs-Stage4
6.466200E-01
Stage2-vs-Stage3
5.289400E-01
Stage2-vs-Stage4
9.007800E-01
Stage3-vs-Stage4
5.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.811900E-04
Normal-vs-AfricanAmerican
3.168200E-01
Normal-vs-Asian
2.458800E-01
Caucasian-vs-AfricanAmerican
8.049200E-01
Caucasian-vs-Asian
9.598200E-01
AfricanAmerican-vs-Asian
8.411800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.109600E-01
Normal-vs-Female
1.350130E-04
Male-vs-Female
4.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.344800E-01
Normal-vs-Age(41-60Yrs)
7.71689999999881E-05
Normal-vs-Age(61-80Yrs)
6.801100E-04
Normal-vs-Age(81-100Yrs)
7.574300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.783400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.593000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.262200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.510400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.467000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.177600E-03
Normal-vs-Daily Drinker
2.047700E-02
Normal-vs-Weekly Drinker
2.934800E-01
Normal-vs-Occasional Drinker
3.043100E-04
Normal-vs-Social Drinker
2.944400E-01
Non Drinker-vs-Daily Drinker
7.524600E-01
Non Drinker-vs-Weekly Drinker
3.404600E-01
Non Drinker-vs-Occasional Drinker
4.373000E-01
Non Drinker-vs-Social Drinker
2.796600E-01
Daily Drinker-vs-Weekly Drinker
5.769400E-01
Daily Drinker-vs-Occasional Drinker
2.318200E-01
Daily Drinker-vs-Social Drinker
4.577800E-01
Weekly Drinker-vs-Occasional Drinker
5.474300E-02
Weekly Drinker-vs-Social Drinker
9.034400E-01
Occasional Drinker-vs-Social Drinker
3.575500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.938800E-01
Normal-vs-Grade 2
9.467800E-01
Normal-vs-Grade 3
6.232800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.974200E-02
Grade 1-vs-Grade 3
4.095100E-03
Grade 1-vs-Grade 4
8.938800E-01
Grade 2-vs-Grade 3
8.256200E-02
Grade 2-vs-Grade 4
9.467800E-01
Grade 3-vs-Grade 4
6.232800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.122290E-02
Normal-vs-NonDiabetic
2.374700E-04
Diabetic-vs-NonDiabetic
3.294000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.416370E-01
Normal-vs-NoPancreatitis
1.037970E-03
Pancreatitis-vs-NoPancreatitis
7.698800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.861780E-01
Normal-vs-N1
1.242910E-04
N0-vs-N1
2.209600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.180000E-02
Normal-vs-TP53-NonMutant
2.420400E-01
TP53-Mutant-vs-TP53-NonMutant
1.74530000451867E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
